Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 157 for “"Bronchiectasis"”.
-
Haemophilus parainfluenzae in bronchiectasis
INTRODUCTION: Bronchiectasis is a chronic airway condition with permanently dilated airways, dysfunctional cilia and overproduction of mucus as main clinical symptoms, and in bronchiectasis there is a continuous cycle involving bacterial infection, host immune response and airway damage (Cole, …
-
The Interferon Response in Bronchiectasis
Bronchiectasis is a chronic respiratory condition characterised by irreversible dilation of the bronchi, leading to recurrent respiratory infections and chronic inflammation. Bacterial infections have been well-recognised as potent inducers of exacerbations for decades. However, recent studies have …
-
Phenotyping outpatient exacerbations in bronchiectasis
Bronchiectasis is a chronic respiratory condition with a wide spectrum of disease severity. There is a pressing need for randomised controlled trials in bronchiectasis to help guide management of this condition which is associated with increased morbidity and mortality. There is paucity of data in …
-
Stenotrophomonas maltophilia in patients with bronchiectasis
Bronchiectasis is an acquired irreversible bronchopulmonary disease where bronchial walls in the lungs are permanently inflamed and dilated. This leads to a ‘vicious cycle’ between chronic bacterial infection and immune dysregulation. One of the bacterial infections patients with bronchiectasis …
-
Self-management in Bronchiectasis: barriers and opportunities
… systematic review of self-management for bronchiectasis found scarce, poor quality evidence. National Bronchiectasis Guidelines recommend self-management including ‘basic principles of disease management’, recognition of exacerbation through health changes requiring action - either by …
-
Clinical significance of IgG2 deficiency in Bronchiectasis
Bronchiectasis is a common chronic debilitating respiratory condition with patients suffering chronic cough, sputum production and recurrent chest infections. Specific immune defects can be associated with bronchiectasis in up to 10% of patients. There are four Immunoglobulin G subclasses (IgG1, …
-
Lipoxin A4 on neutrophil reprogramming in bronchiectasis
INTRODUCTION Bronchiectasis is a common chronic debilitating respiratory condition. Patients suffer daily cough, excess sputum production and recurrent chest infections because of inflamed and permanently damaged airways. The pathogenesis of bronchiectasis is poorly understood. Pulmonary pathology …
-
A clinical study of bronchiectasis in children
1. Bronchiectasis is not an uncommon disease in children. • 2. It affects males and females equally. • 3. Most cases arise in the acute respiratory diseases of infancy or early childhood. • 4. A congenital form exists, but most cases are acquired. • 5. The acquired cases may be secondary to …
-
Management of bronchiectasis: a tertiary health care perspective
Bronchiectasis is a chronic, progressive disease of the airways which is characterised by persistent cough, excessive sputum, difficulty in clearing airway secretions and recurrent infections. In the last decade several guidelines for the management of bronchiectasis have been developed. These …
-
Assessment of health status and cough in bronchiectasis
Bronchiectasis is a chronic debilitating disease, where the airways are abnormally and permanently dilated. Bronchiectasis treatment aims to reduce cardinal symptoms, such as cough, whilst the ultimate therapeutic target is to improve the patient’s health-related quality of life (HRQOL). …
-
Characterisation of blood and airway neutrophils in bronchiectasis
Bronchiectasis is a chronic progressive respiratory disease with wide-ranging aetiology. In bronchiectasis, interplay of a ‘vicious vortex’ of lung structural remodeling, inflammation, impaired mucociliary clearance, and infection exacerbates each other.<br/><br/>Inflammation in bronchiectasis is …
-
Development of meaningful clinical trial endpoints in bronchiectasis
Bronchiectasis is an increasing clinical problem, with no licensed treatments because multiple recent clinical trials have failed to reach their primary endpoint. Difficulties in achieving “positive” bronchiectasis trials is reflected in a lack of agreement from trialists and regulators on what are …
-
Bronchiectasis as a phenotype of Alpha-1 Antitrypsin Deficiency
… disease (COPD), but its relationship with bronchiectasis, a condition involving permanent bronchial dilatation, recurrent infections, and impaired mucociliary clearance, is less well defined. This thesis investigates the hypothesis that bronchiectasis in AATD represents a distinct clinical …
-
Lectin pathway of complement and bacterial colonisation in bronchiectasis
Bronchiectasis is a chronic inflammatory lung disease associated with failure of the normal mucociliary escalator, chronic bacterial colonisation of the airways, neutrophil mediated inflammation and a resulting clinical syndrome of respiratory infections, lung damage and symptoms such as cough, …
-
A 'Pretty Normal' Life With Bronchiectasis. An Interpretive Description.
Bronchiectasis is a chronic respiratory disease in which recurrent infection and inflammation cause abnormal and permanent dilatation of the airways resulting in recurrent respiratory infections and a chronic wet cough. It is a significant health issue in New Zealand, particularly amongst Māori and …
-
Relationship between antibiotic treatment and clinical outcome in people with bronchiectasis
In bronchiectasis (BE), chronic bacterial infection contributes to pulmonary exacerbations, clinical decline, and increased morbidity and mortality. Bacterial load correlates with airway inflammation and exacerbation risk, supporting the use of long-term inhaled antibiotics. While microbial culture …
-
Ciprofloxacin resistance in <i>Pseudomonas aeruginosa</i> from people with bronchiectasis
Bronchiectasis is a chronic respiratory condition characterised by irreversible bronchial damage and dilation, with Pseudomonas aeruginosa infections linked to increased hospitalisations and poor outcomes. Ciprofloxacin, a key antibiotic for P. aeruginosa eradication and managing pulmonary …
Page 1 of 8